OCUL insider trades & Congress trades
Ocular Therapeutix, Inc: public insider filings and Congress disclosures, in one place.
Bourse has recorded 8 open-market insider transactions in Ocular Therapeutix, Inc (OCUL) (0 purchases with code P and 8 sales with code S), the most recent on October 8, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 8 sales by 6 ($568K).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | Sell | 11,984 | $7.29 | $87K | – |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | Sell | 9,990 | $7.05 | $70K | – |
| Oct 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,869 | $7.05 | $77K | – |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | Sell | 1,099 | $10.24 | $11K | −0.3% |
| Aug 24, 2026 | Dugel Pravin | See Remarks | Sell | 21,649 | $10.77 | $233K | −0.1% |
| Aug 24, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,296 | $10.78 | $36K | −0.1% |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,897 | $10.78 | $20K | −0.1% |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | Sell | 3,035 | $10.77 | $33K | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.